This page shows the latest Argentina news and features for those working in and with pharma, biotech and healthcare.
Repik added that the trials are set to be conducted in Azerbaijan, Argentina, Saudi Arabia, the UAE, Belarus, Russia and other locations.
months. The AZ/Oxford vaccine has now been granted emergency authorisation in a range of countries including Argentina, Dominican Republic, El Salvador, Mexico and Morocco.
Pfizer/BioNTech plan to enrol 30, 000 participants into the phase 2/3 efficacy and safety trial, which is actively enrolling in the US, Argentina and Brazil, with further planned enrolment
Pfizer/BioNTech plan to enrol 30, 000 participants into the phase 2/3 efficacy and safety trial, which is now actively enrolling in the US, Argentina and Brazil, with further planned
This number exceeds the total number of active ventilators in Mexico, Colombia, Argentina and Chile combined by 13, 000.
Campaigners and patient groups have continually called for access, and a dedicated buyers’ club has been set up to source the medicines in Argentina, where Vertex does not hold a patent
More from news
Approximately 0 fully matching, plus 44 partially matching documents found.
A good example is Pfizer’s COVID-19 vaccine trial, which was conducted at around 150 trial sites across the US, Argentina, Brazil, South Africa, Germany and Turkey.
Because Vertex holds no patent in Argentina, Gador is able to manufacture its version of the drug, which in turn means that patients in the UK can access the drug via
For example, there's nothing in common between Indonesia and Argentina, whereas Argentina and France don't look that different. ... In Brazil and Argentina, for example, insurers have negotiated deals with pharmaceutical companies for total payment caps,
However, it anticipates Mexico will be overtaken by both Argentina and Venezuela in the same period.
Argentina's average study approval time is six months while in Brazil the process may take nearly a year.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Dr Sherif joined Switzerland-based Novartis in 2002 as global sales manager before moving to Argentina in 2004 to take on senior Novartis positions in Latin America.
Taking up on the position on February 1, Dr Etienne succeeds Argentina's Dr Mirta Roses Periago who leaves after 10 years in the position.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Presently, the company has specialists in more than ten countries, including the United States, Canada, Argentina, France, Spain, Germany, Poland, and Ukraine.
The diversity is also economic. Recent years have seen marked improvements in income distribution and a burgeoning middle class, particularly in countries such as Argentina, Bolivia, Ecuador, Peru and Nicaragua.
The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.
Latin America. The LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.
Setting the scene: The opportunity. With a population of 45 million people, Colombia is the third largest Latin American country behind Brazil and Mexico, having recently overtaken Argentina.
More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...